文献速递运动医学关节外科

阿片类未暴露患者常见肩关节镜术后长期阿片类用药风险

Risk of Prolonged Opioid Use Among Opioid-Naïve Patients After Common Shoulder Arthroscopy Procedures.
PubMed 文献 · Am J Sports Med · 2019-02-08

基于保险理赔数据的病例对照研究,纳入2010年1月1日至2015年3月31日间接受肩关节镜手术的阿片类未暴露成人患者104154例,其中8686例(8.3%)出现新的长期阿片类用药。围手术期阿片类总剂量≥743口服吗啡当量、自杀与自伤障碍、酒精依赖或滥用、心境障碍、术前30天内阿片类处方、女性、焦虑障碍及疼痛诊断史与长期用药风险升高相关。

要点

  • 肩关节镜术后新发长期阿片类用药比例为8.3%(8686/104154)。
  • 围手术期阿片类总剂量≥743口服吗啡当量者风险最高(OR 2.0;95%CI 1.9-2.1)。
  • 女性、精神心理疾病、物质依赖及疼痛诊断史与风险升高相关。

核心结论

  • 肩关节镜术后长期阿片类用药风险为8.3%,女性、术后早期阿片类用量较大、精神心理疾病、物质依赖与滥用及既往疼痛障碍者风险更高。
  • 作者认为高危患者术后需要密切监测,以便早期识别和管理。

研究设计与样本

  • 病例对照研究,证据等级3。
  • 使用Truven Health MarketScan研究数据库的保险理赔数据,识别2010年1月1日至2015年3月31日期间接受肩关节镜手术的阿片类未暴露患者。
  • 新发长期阿片类用药定义为索引手术后91至180天之间持续使用阿片类药物。
  • 采用多变量逻辑回归模型识别与长期阿片类用药风险相关的患者因素。

主要发现

  • 104154例阿片类未暴露成人患者中,8686例(8.3%)出现新的长期阿片类用药。
  • 31768例(30.5%)在手术前30天内配取过阿片类处方。
  • 长期用药比例:有限清创组9.0%最高,其次为肩袖修复组8.5%、前盂唇损伤修复组8.5%、广泛清创组8.2%。
  • 围手术期阿片类总剂量≥743口服吗啡当量(相当于至少149片5毫克氢可酮)者OR 2.0(95%CI 1.9-2.1)。
  • 自杀与自伤障碍者OR 2.0(95%CI 1.1-3.4),酒精依赖或滥用史者OR 1.6(95%CI 1.3-1.9)。

临床怎么用

  • 作者认为高危患者术后需要密切监测,以便早期识别和管理长期阿片类用药。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Opioid-related morbidity and mortality are major public health concerns, and the risk of long-term opioid use after shoulder arthroscopy is not well defined. HYPOTHESIS: Substance abuse disorders, pain disorders, and psychiatric conditions increase the risk for prolonged opioid use. STUDY DESIGN: Case-control study, Level of evidence, 3. METHODS: Insurance claims data from the Truven Health MarketScan Research Databases was used to identify patients who underwent shoulder arthroscopy between January 1, 2010, and March 31, 2015. Opioid-naïve patients were included. New prolonged opioid use was defined as continued opioid use between 91 and 180 days after the index procedure. The authors used a multivariable logistic regression model to identify patient factors associated with the risk of new prolonged opioid use. RESULTS: In this cohort of 104,154 opioid-naïve adult patients, 8686 (8.3%) developed new prolonged opioid use as defined in this study. A total of 31,768 (30.5%) filled an opioid prescription in the 30 days before surgery. Patients who had limited debridement had the highest prolonged use rate (9.0%), followed by rotator cuff repair (8.5%), anterior labrum lesion repair (8.5%), and extensive debridement (8.2%). Patient characteristics associated with the highest odds ratios (ORs) of prolonged opioid use included those who had a total opioid dose during the perioperative period that was ≥743 oral morphine equivalents (ie, at least 149 tablets of 5-mg hydrocodone) (OR, 2.0; 95% CI, 1.9-2.1), followed by patients with a suicide and self-harm disorder (OR, 2.0; 95% CI, 1.1-3.4), a history of alcohol dependence or abuse (OR, 1.6; 95% CI, 1.3-1.9), a mood disorder (OR, 1.3; 95% CI, 1.2-1.4), an opioid prescription filled in the 30 days before surgery (OR, 1.3; 95% CI, 1.2-1.4), female sex (OR, 1.3; 95% CI, 1.2-1.3), an anxiety disorder (OR, 1.2; 95% CI, 1.1-1.3), and a history of a pain diagnosis (OR, 1.2; 95% CI, 1.1-1.2). CONCLUSION: The risk of prolonged opioid use after arthroscopic shoulder procedures is 8.3%, and it is higher among women and among those with greater opioid use in the early postoperative period, mental health conditions, substance dependence and abuse, and preexisting pain disorders. Patients at high risk warrant close surveillance after surgery for early recognition and management.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Gil JA, Gunaseelan V, DeFroda SF, et al. Risk of Prolonged Opioid Use Among Opioid-Naïve Patients After Common Shoulder Arthroscopy Procedures. Am J Sports Med. 2019. PMID: 30735622. doi:10.1177/0363546518819780

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。